FIELD: medicine. SUBSTANCE: preparation consists of the core and envelope. Component ratio in core, g: pollenase 0.0490-0.0510; sodium chloride 0.0180-0.0188; mannitol 0.0361-0.0380; calcium stearate 0.0010-0.0012; aerosil 0.0030-0.0039. Component ratio in envelope, g: acetylphthalylcellulose 0.008650-0.008655; titanium dioxide 0.001334-0.001337, and acid red 2C 0.000011-0.000013. EFFECT: increased effectiveness of preparation for treatment. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING THE CASES OF PANCREAS DISEASES AND DIGESTION DISORDERS RELATED TO HEPATIC DISEASES | 2004 |
|
RU2276985C1 |
PHARMACEUTICAL COMPOSITION USING IN PANCREAS DISEASES | 2002 |
|
RU2207847C1 |
FERESTAL POLYENZYMATIC PREPARATION | 2001 |
|
RU2201763C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTI-INFLAMMATORY ACTIVITY | 2001 |
|
RU2196570C1 |
AGENT "ALIPRIL" FOR TREATMENT OF PATIENTS WITH ATHEROSCLEROSIS | 1998 |
|
RU2129001C1 |
DELAYED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING ASPARAGINATES | 2016 |
|
RU2632713C2 |
METHOD FOR PRODUCING MEDICINAL AGENTS - NITROGEN-CONTAINING BETAINES OF HYDROCHLORIDES - BASED ON POST-DISTILLED CORN SILAGE | 2019 |
|
RU2736186C1 |
MEDICINAL AGENT "GASTROPEK" FOR IMPROVING DIGESTION PROCESS AND METHOD FOR ITS USING | 2004 |
|
RU2276974C2 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457855C2 |
Authors
Dates
1996-04-10—Published
1992-07-04—Filed